Biotechnology Waste Management Law In Ukraine.
1. Introduction
Biotechnology Waste Management Law in Ukraine is the legal framework governing the collection, segregation, transportation, storage, treatment, recycling, disinfection and disposal of waste generated by biotechnology industries, pharmaceutical laboratories, hospitals, genetic research institutions, vaccine manufacturers, microbiological facilities and biological research centres.
Biotechnology waste presents particular legal and environmental risks because it may contain:
Genetically modified organisms (GMOs).
Infectious microorganisms and pathogenic biological materials.
Human and animal tissues, blood and biological specimens.
Pharmaceutical residues, vaccines and expired biological products.
Laboratory chemicals and contaminated equipment.
Genetically engineered biological materials.
Biological waste capable of contaminating soil, water and ecosystems.
Ukraine regulates these activities through environmental protection legislation, waste-management legislation, public-health rules, pharmaceutical regulation, chemical safety requirements and legislation governing genetically modified organisms.
An important distinction is that Ukraine does not have one comprehensive statute exclusively dedicated to biotechnology waste. Instead, several interconnected legal regimes apply according to the nature, origin and hazardous characteristics of the waste.
2. Main Legislative Framework
A. Law of Ukraine No. 2320-IX on Waste Management (2022)
The principal legislation is the Law of Ukraine on Waste Management.
It establishes the general legal framework for waste prevention, classification, collection, transportation, recovery, recycling and disposal.
Its important principles include:
Waste prevention: Biotechnology enterprises should reduce the generation of biological and hazardous waste.
Polluter pays: The waste generator or owner bears the relevant costs of lawful waste management.
Waste hierarchy: Prevention, preparation for reuse, recycling, recovery and finally disposal.
Environmental protection: Waste operations must not endanger human health or the environment.
Extended producer responsibility: Producers may bear responsibilities for waste generated by products within applicable statutory schemes.
Hazardous waste control: Hazardous waste must be handled through the applicable authorization, licensing and safety framework.
The legislation also regulates waste transported through Ukraine and waste imported or exported for recovery.
An important exception is that the Act excludes certain categories, including radioactive waste and animal by-products, which may be subject to separate legislation.
Application to biotechnology: A pharmaceutical manufacturer generating contaminated laboratory materials cannot treat them as ordinary commercial waste merely because they originate from a production facility. Their classification and hazardous characteristics determine the applicable legal requirements.
on June 20, 2022 № 2320-IX+1
B. Law No. 3339-IX on Genetic Engineering and GMOs (2023)
The Law No. 3339-IX on State Regulation of Genetic Engineering Activities establishes the framework for genetic-engineering activities, biosafety and state control over genetically modified organisms and products.
In force since 16 September 2026
This legislation is particularly important for biotechnology waste because it addresses:
Genetic engineering in contained systems.
Research and testing of GMOs in open systems.
GMO registration.
Environmental and biological safety.
GMO monitoring and state control.
Withdrawal and destruction of certain non-compliant GMO products.
Article 1 defines biosafety by reference to preventing or eliminating irreversible negative effects of GMOs on human health, other living organisms and the environment.
Article 3 also addresses the handling of GMOs in open and contained systems, including storage, transportation, destruction and burial.
Legal significance: A biotechnology company dealing with genetically modified microorganisms must consider both the GMO-specific biosafety framework and the general waste-management regime. Compliance with one does not automatically satisfy the other.
on August 23, 2023 № 3339-IX+2
C. Law on Environmental Protection (1991)
The Law of Ukraine No. 1264-XII on Environmental Protection establishes general environmental obligations.
Its relevance to biotechnology waste includes:
Prevention of environmental pollution.
Protection of water, soil and air.
Environmental safety requirements.
Compensation for environmental damage.
Government supervision and enforcement.
A biotechnology enterprise that releases untreated biological waste into rivers or agricultural land may face environmental liability even if the waste originated from a licensed research institution.
D. Law on Environmental Impact Assessment (2017)
The Law No. 2059-VIII on Environmental Impact Assessment (EIA) is relevant where a proposed biotechnology project falls within the statutory categories of activities requiring environmental assessment.
For example, a large-scale pharmaceutical manufacturing facility, waste-treatment installation or industrial biological-processing plant may require an EIA depending on its characteristics and statutory classification.
The assessment can examine:
Potential biological contamination.
Effects on groundwater and surface water.
Soil contamination.
Air emissions from waste treatment.
Risks arising from accidental releases.
Proposed waste-treatment and emergency-control systems.
The operator must not assume that every biotechnology laboratory automatically requires an EIA. The statutory activity categories and applicable thresholds must be examined.
zakon.rada.gov.ua+1
E. Chemical Safety Legislation
The Law No. 2804-IX on Ensuring Chemical Safety and Management of Chemical Products is relevant where biotechnology waste contains hazardous laboratory chemicals, solvents, disinfectants, reagents or other regulated chemical substances.
A mixed waste stream may therefore attract both chemical-safety and waste-management obligations.
3. Medical and Biological Waste Management Regulations
One of the most important regulatory instruments is Ministry of Health Order No. 1827 of 31 October 2024.
It approved the State Sanitary Standards and Rules on Medical Waste Management.
Effective 1 April 2025
The order replaced the earlier Ministry of Health Order No. 325 of 2015.
It regulates medical waste management by healthcare institutions, licensed medical practitioners, forensic institutions, relevant non-governmental organizations and authorized waste-management businesses.
It establishes requirements concerning:
Generation of medical waste.
Collection and segregation.
Storage.
Transportation.
Treatment and processing.
Protection of human health.
Safe handling by waste-management personnel.
It also identifies the importance of authorized waste-management operators. Relevant operators must possess the required waste-treatment authorization and hazardous-waste management licence, as applicable.
від 31.10.2024 № 1827+1
Categories of biotechnology waste
| Category | Examples | Main legal concern |
|---|---|---|
| Infectious waste | Pathogen cultures, contaminated materials | Infection prevention |
| GMO waste | Genetically modified microorganisms | Biosafety and containment |
| Pharmaceutical waste | Expired vaccines, biological medicines | Safe destruction |
| Anatomical waste | Human tissues and specimens | Sanitary and ethical controls |
| Sharps waste | Needles, contaminated glass | Occupational safety |
| Chemical waste | Laboratory reagents and solvents | Hazardous-waste controls |
| Animal biological waste | Experimental animal materials | Separate applicable animal by-product rules |
Classification must be based on the applicable waste catalogue and actual characteristics, rather than simply the name given to the material by the laboratory.
4. Classification and Identification of Biotechnology Waste
Ukraine's waste-classification framework is supported by Cabinet of Ministers Resolution No. 1102 of 20 October 2023, which approves the procedure for waste classification and the National Waste List.
This classification is important because different waste categories carry different legal requirements.
For example:
Example 1: Pharmaceutical laboratory
A laboratory produces expired vaccine samples, contaminated syringes and chemical reagents.
The operator must identify the individual waste streams, classify them correctly and arrange appropriate treatment or disposal.
Example 2: GMO research centre
A research institution produces genetically modified bacterial cultures.
It must assess the applicable GMO biosafety requirements alongside waste classification and treatment obligations. The material cannot simply be released into ordinary municipal waste.
Example 3: Biotechnology manufacturing company
A manufacturing facility produces biological residues and contaminated filtration materials.
It must establish whether each waste stream is hazardous, arrange suitable containment and use appropriately authorized operators.
zakon.rada.gov.ua+2
5. Licensing and Authorization Requirements
Biotechnology waste management may involve several different regulatory permissions.
Under the waste-management framework, hazardous-waste operations are subject to licensing requirements. Waste-treatment activities are also subject to the applicable permit requirements.
Cabinet of Ministers Resolution No. 1278 of 5 December 2023 establishes licensing conditions for economic activities involving hazardous-waste management.
A company intending to provide hazardous biotechnology waste treatment services should examine:
Whether its activities require a hazardous-waste management licence.
Whether a waste-treatment permit is required.
Whether its personnel possess the necessary qualifications.
Whether its premises and treatment equipment satisfy applicable safety requirements.
Whether its transportation activities require separate licensing.
Whether its records and reporting comply with waste-management legislation.
A biotechnology research institution that generates waste and a commercial enterprise that treats hazardous waste may have different legal responsibilities.
Important: A contract with a waste-management company does not automatically eliminate the original generator's legal obligations. The generator must ensure that waste is transferred and managed through a lawful process.
zakon.rada.gov.ua+1
6. Transportation, Storage and Treatment
A. Collection and segregation
Biotechnology laboratories should separate waste at the point of generation.
Infectious materials, sharps, chemical waste, pharmaceutical residues and ordinary non-hazardous waste should not be mixed indiscriminately.
B. Storage
Storage facilities should be designed to prevent:
Leakage of infectious materials.
Unauthorized access.
Accidental exposure.
Contamination of surrounding soil and water.
Uncontrolled release of biological organisms.
Storage arrangements must comply with the relevant sanitary and waste-management requirements.
C. Transportation
Hazardous biotechnology waste must be transported using the legally required arrangements.
The operator should maintain appropriate documentation identifying the waste, its classification, the sender, transporter, recipient and relevant treatment arrangements.
D. Treatment
Depending on the material and applicable approvals, treatment may include:
Validated thermal treatment.
Autoclaving.
Chemical disinfection.
Specialized pharmaceutical waste treatment.
Other authorized biological or physical treatment processes.
Not every treatment method is suitable for every type of biotechnology waste. For example, treatment that inactivates infectious microorganisms does not necessarily remove chemical toxicity or make every genetically modified material suitable for unrestricted disposal.
E. Final disposal
The final disposal method must comply with the waste classification, treatment requirements and applicable environmental permissions.
Untreated infectious waste should not be discharged into ordinary sewage systems or deposited at unauthorized landfill sites.
7. Environmental Liability and Legal Penalties
Biotechnology companies, laboratories and waste-treatment operators may face different forms of legal liability.
A. Administrative liability
Administrative liability may arise from violations of waste-management, sanitary and environmental requirements.
Possible violations include:
Improper storage of infectious waste.
Failure to comply with waste-segregation requirements.
Unauthorized waste-treatment activities.
Incorrect waste classification.
Breach of transportation requirements.
Failure to maintain required documentation.
The applicable penalties depend on the particular statutory provision and the nature of the violation.
B. Civil liability
A biotechnology enterprise may be required to compensate for environmental damage caused by unlawful waste disposal.
Compensation may relate to:
Soil contamination.
Groundwater pollution.
Damage to agricultural land.
Harm to ecosystems.
Costs of environmental restoration.
Proven personal injury or property damage.
C. Criminal liability
Depending on the facts and the elements of the offence, relevant provisions of the Criminal Code of Ukraine may include:
| Provision | Subject |
|---|---|
| Article 236 | Violation of environmental safety rules |
| Article 239 | Pollution or damage to land |
| Article 325 | Violation of sanitary rules and norms concerning prevention of infectious diseases and mass poisoning |
| Article 326 | Violation of rules governing microbiological or other biological agents and toxins |
These provisions are not automatically applicable to every waste-management violation. Prosecutors must establish the statutory elements, including the required consequences, culpability and causal connection.
8. Important Case Laws and Judicial Principles
Important research qualification: Ukrainian reported judgments specifically addressing genetically modified laboratory waste or biotechnology waste disposal are limited. The following decisions concern environmental pollution, hazardous waste, unauthorized landfills and environmental evidence. They provide relevant legal principles, but should not be misrepresented as direct GMO-waste precedents.
Case 1. Dubetska and Others v. Ukraine (2011)
European Court of Human Rights
Court: European Court of Human Rights.
Application No.: 30499/03.
Judgment date: 10 February 2011.
Legal provision: Article 8, European Convention on Human Rights.
Facts
The applicants lived near a coal mine and a coal-processing factory. Their complaints concerned pollution from industrial facilities and associated waste heaps.
They argued that pollution had adversely affected their health, living conditions, water quality and homes.
Legal issue
Whether the Ukrainian authorities had failed to fulfil their positive obligations to protect individuals from serious environmental pollution.
Judgment
The ECtHR found a violation of Article 8.
It emphasized that the authorities had failed to strike a fair balance between the applicants' rights and the public interest in operating the industrial facilities.
Relevance to biotechnology waste
This judgment is relevant where biological or pharmaceutical waste causes serious environmental pollution affecting nearby communities.
A biotechnology enterprise cannot rely solely on the economic or scientific importance of its operations to avoid environmental responsibilities.
Legal principle: States have positive obligations to protect individuals against serious environmental interference affecting their private and family life.
Source:
hudoc.echr.coe.int+1
Case 2. Supreme Court of Ukraine – Case No. 369/7171/16 (5 April 2023)
Court: Supreme Court of Ukraine.
Date: 5 April 2023.
Subject: Pollution caused by a solid-waste landfill and protection of environmental rights.
Facts
The dispute involved residents seeking termination of the operation of a solid-waste landfill and compensation for moral damage.
The applicants alleged that unlawful landfill operations had caused pollution affecting their surrounding environment, including soil, air and water.
Legal significance
The decision is relevant to the relationship between waste-management violations, environmental protection and the rights of residents.
Application to biotechnology
Where a biotechnology facility improperly disposes of biological waste at a landfill, affected residents may seek appropriate judicial remedies if the necessary legal and evidentiary requirements are satisfied.
The case provides an example of domestic judicial protection against environmental harm.
dspace.uzhnu.edu.ua
Case 3. Supreme Court of Ukraine – Case No. 910/7638/24 (11 February 2026)
Supreme Court decision
Court: Commercial Cassation Court of the Supreme Court.
Date: 11 February 2026.
Subject: Liquidation of an unauthorized landfill.
Facts
An unauthorized landfill had been established on communally owned land.
The enterprise had failed to comply with an environmental inspectorate's order to eliminate the violations.
The prosecutor brought proceedings seeking liquidation of the unauthorized landfill.
Legal issue
Whether the courts could rely on evidence from criminal pre-trial proceedings when deciding the environmental dispute.
Judgment
The Supreme Court emphasized that information from a pre-trial investigation may be disclosed only with the permission of an investigator or prosecutor.
However, the courts had also relied on independent evidence, including:
Environmental inspection reports.
Official enforcement orders.
Environmental inspector certificates.
Satellite imagery.
Other admissible evidence.
The Supreme Court upheld the outcome requiring the unauthorized landfill to be liquidated.
Relevance to biotechnology waste
This decision is useful where a biotechnology waste operator uses an unauthorized landfill or illegally deposits infectious or hazardous biological materials.
It demonstrates the importance of independent, properly obtained environmental evidence.
Source: Supreme Court, Resolution of 11 February 2026, Case No. 910/7638/24.
court.gov.ua
Case 4. Supreme Court of Ukraine – Case No. 922/3834/25 (2 September 2026)
Court: Commercial Cassation Court of the Supreme Court.
Date: 2 September 2026.
Subject: Environmental damage and evidentiary requirements.
Facts
The dispute concerned environmental damage associated with land contamination involving animal-origin waste and pollutants.
The environmental authorities relied on inspection records, soil measurements and an approved damage-calculation methodology.
Legal issue
Whether the evidence collectively established environmental damage and the defendant's obligation to compensate the State.
Judgment
The Supreme Court held that the evidence had to be assessed collectively rather than by examining each item in isolation.
The relevant evidence included:
Environmental inspection reports.
Official enforcement orders.
Soil-testing protocols.
Damage calculations under an approved methodology.
The defendant's acknowledgment of the violation.
The Court restored the first-instance judgment requiring compensation.
Relevance to biotechnology waste
This case is particularly relevant to biotechnology waste litigation because biological contamination may require laboratory testing and scientific assessment.
For example, where a pharmaceutical manufacturer releases biological waste into agricultural soil, environmental authorities may need:
Soil and water sampling.
Microbiological testing.
Identification of hazardous substances.
Expert evidence.
Scientific assessment of environmental damage.
A legally approved method of calculating compensation.
Legal principle: Environmental damage can be established through the combined evidentiary value of technical, scientific and official inspection materials.
Source: Supreme Court, Resolution of 2 September 2026, Case No. 922/3834/25.
court.gov.ua
Case 5. ArcelorMittal Kryvyi Rih Soil Pollution Proceedings (2024)
Court: Industrial District Court of Dnipro.
Ruling date: 16 December 2024.
Court ruling No.: 123842517.
Criminal proceeding No.: 42024040000000365.
Facts
Investigators examined allegations that industrial waste had been illegally processed and buried on a large land parcel without the required permits.
The investigation concerned companies allegedly involved in the disposal of industrial waste and resulting soil contamination.
Judicial significance
The court approved a prosecutor's application for seizure of property connected with the investigation.
Relevance to biotechnology
The proceedings illustrate the potential use of criminal investigative measures where hazardous waste is allegedly buried unlawfully and causes environmental risks.
However, this was an industrial-waste pollution investigation, not a biotechnology-waste judgment, and the seizure ruling should not be treated as a final determination of criminal guilt.
Business and Human Rights Centre
9. Regulatory Responsibilities of Biotechnology Companies
The following table summarizes the practical responsibilities of different organizations.
| Organization | Principal responsibilities |
|---|---|
| Biotechnology laboratories | Classification, segregation and safe storage |
| Pharmaceutical manufacturers | Management of expired and contaminated products |
| Vaccine producers | Safe management of biological production residues |
| GMO research institutions | GMO containment and lawful destruction |
| Hospitals | Compliance with medical-waste sanitary rules |
| Waste-treatment companies | Required licences, permits and safe treatment |
| Universities | Laboratory waste-management systems |
| Environmental authorities | Inspection and enforcement |
10. International Legal Framework
Ukraine's biotechnology waste-management system is also influenced by international environmental and biosafety obligations.
A. Basel Convention on the Control of Transboundary Movements of Hazardous Wastes
The Basel Convention regulates the transboundary movement and environmentally sound management of hazardous waste.
Its relevance includes:
International movement of hazardous laboratory waste.
Export and import of hazardous biological waste where covered by the Convention.
Prior informed consent procedures.
Environmentally sound disposal.
Prevention of illegal international waste trafficking.
B. Cartagena Protocol on Biosafety
The Cartagena Protocol on Biosafety concerns the safe handling, transport and use of living modified organisms resulting from modern biotechnology.
It is relevant to biotechnology activities involving living modified organisms that may affect biodiversity.
C. Convention on Biological Diversity
The Convention on Biological Diversity provides the broader international framework for biodiversity conservation, sustainable use and biosafety-related cooperation.
D. European Union Environmental Standards
Ukraine's environmental legislation is also influenced by its European integration commitments.
Important EU instruments include:
Directive 2008/98/EC on waste.
Directive 2010/75/EU on industrial emissions.
Directive 2011/92/EU on environmental impact assessment.
Directive 2009/41/EC on contained use of genetically modified microorganisms.
Directive 2001/18/EC on deliberate release of genetically modified organisms.
These instruments provide important reference points for regulatory approximation, although EU directives do not automatically operate as Ukrainian domestic legislation without the relevant legal implementation.
11. Major Legal Challenges
Ukraine faces several important regulatory challenges in biotechnology waste management.
1. Classification difficulties
Some biological materials contain infectious microorganisms, chemicals and genetically modified components simultaneously. Determining the correct waste classification can therefore be complex.
2. GMO containment
Accidental release of genetically modified microorganisms may create risks to biodiversity and public health.
3. Pharmaceutical waste
Expired vaccines, biological medicines and contaminated pharmaceutical products require specialized handling and destruction.
4. Illegal disposal
Unauthorized dumping and improper treatment can cause long-term environmental contamination.
5. Scientific evidence
Determining the source and extent of biological contamination may require sophisticated laboratory testing and expert evidence.
6. Infrastructure limitations
Specialized biological waste-treatment facilities, trained personnel and monitoring systems are necessary for effective enforcement.
7. Wartime environmental risks
Damage to laboratories, pharmaceutical manufacturing plants and hazardous-waste storage facilities may create additional risks of biological and chemical contamination.
12. Practical Compliance Framework for Biotechnology Enterprises
A biotechnology enterprise operating in Ukraine should implement the following compliance structure.
Biotechnology waste compliance cycle
Waste identification
Identify all biological, infectious, chemical, pharmaceutical and GMO waste streams.
Legal classification
Apply the National Waste List and relevant hazardous-waste classification rules.
Segregation and containment
Separate waste and prevent accidental exposure or environmental release.
Authorized transportation
Verify the relevant qualifications, licences and documentation.
Treatment and destruction
Select a legally authorized and technically appropriate treatment method.
Final disposal and records
Maintain transfer documents, treatment records, monitoring results and required reports.
Environmental auditing
Conduct periodic inspections and corrective-action assessments.
Essential compliance documents
A biotechnology enterprise should maintain, as applicable:
Waste inventory and classification records.
Internal waste-management procedures.
Hazardous-waste licences and treatment permits.
Waste transportation documentation.
Contracts with authorized waste operators.
GMO biosafety documentation.
Laboratory safety procedures.
Environmental monitoring reports.
Treatment and destruction certificates.
Emergency response procedures.
13. Conclusion
Biotechnology Waste Management Law in Ukraine represents an interconnected system of environmental protection, public-health regulation, hazardous-waste control and genetic-engineering biosafety.
The central legislation is Law No. 2320-IX on Waste Management, supported by Ministry of Health Order No. 1827 of 2024 and the GMO regulatory framework under Law No. 3339-IX.
The legal framework places substantial responsibility on biotechnology companies, research institutions, pharmaceutical manufacturers and waste-treatment operators to prevent biological contamination and ensure environmentally sound waste management.
The judicial decisions discussed above demonstrate three particularly important principles:
Environmental authorities and enterprises must respect statutory waste-management requirements.
Scientific and technical evidence can play an important role in establishing environmental damage.
Serious environmental pollution may engage both domestic legal remedies and fundamental human rights protections.
Ultimately, biotechnology waste management in Ukraine is not merely a technical issue of laboratory sanitation. It is a matter of environmental accountability, public health, biosafety, corporate responsibility and sustainable development.
14. Important Legal Sources and Further Research
| Legal source | Subject |
|---|---|
| Law No. 2320-IX (2022) | Waste management |
| Law No. 3339-IX (2023) | Genetic engineering and GMO regulation |
| Law No. 1264-XII (1991) | Environmental protection |
| Law No. 2059-VIII (2017) | Environmental impact assessment |
| Law No. 2804-IX (2022) | Chemical safety |
| Resolution No. 1102 (2023) | Waste classification |
| Resolution No. 1278 (2023) | Hazardous-waste licensing |
| Ministry of Health Order No. 1827 (2024) | Medical waste management |
Primary legal and judicial resources:
Official Waste Management Law – Verkhovna Rada.
Medical Waste Management Rules – Order No. 1827.
National Waste Classification Rules.
Supreme Court judgment – Case No. 910/7638/24.
ECtHR – Dubetska and Others v. Ukraine.
Academic note: The case-law discussion distinguishes direct biotechnology-waste precedents from analogous environmental and hazardous-waste decisions. This distinction is important when using the material in a dissertation, research paper or legal examination.

comments